Search Results 1491-1500 of 19970 for Receptor
Memantine hydrochloride may enhance cognitive function by binding to and inhibiting channels of receptors located in the central nervous system. Radiation ...
... receptor, death receptor 3. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
... receptors or the synthesis of these hormones within 3 months prior to randomization; Current use of high-dose selective beta2-adrenergic drug therapy; Ongoing ...
Baricitinib is used alone or together with other medicines (eg, methotrexate, DMARDs) to treat moderately to severely active rheumatoid arthritis in patients ...
Glucagon-like Peptide-1 Receptor Agonists in Liver Transplant Recipients: A Retrospective Cohort Study. Transplant Direct. 2026 Apr; 12 (4):e1932 Epub 2026 ...
Patients who had endocrine receptor-positive disease and opted out of endocrine therapy had higher LR rates. This underscores the importance of endocrine ...
Received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent or with an agent directed to another stimulatory or co-inhibitory T-cell receptor ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.